SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-000998
Filing Date
2023-01-04
Accepted
2023-01-04 17:49:03
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm231707-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm231707-1_4seq1.xml 4 7404
  Complete submission text file 0001104659-23-000998.txt   9220
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38114 | Film No.: 23508443
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations